1. Home
  2. SMX vs APLM Comparison

SMX vs APLM Comparison

Compare SMX & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMX
  • APLM
  • Stock Information
  • Founded
  • SMX N/A
  • APLM 2016
  • Country
  • SMX Ireland
  • APLM United States
  • Employees
  • SMX N/A
  • APLM N/A
  • Industry
  • SMX Industrial Machinery/Components
  • APLM Blank Checks
  • Sector
  • SMX Technology
  • APLM Finance
  • Exchange
  • SMX Nasdaq
  • APLM Nasdaq
  • Market Cap
  • SMX 6.7M
  • APLM 6.8M
  • IPO Year
  • SMX N/A
  • APLM N/A
  • Fundamental
  • Price
  • SMX $1.25
  • APLM $5.87
  • Analyst Decision
  • SMX
  • APLM
  • Analyst Count
  • SMX 0
  • APLM 0
  • Target Price
  • SMX N/A
  • APLM N/A
  • AVG Volume (30 Days)
  • SMX 11.1M
  • APLM 64.6K
  • Earning Date
  • SMX 01-01-0001
  • APLM 08-13-2025
  • Dividend Yield
  • SMX N/A
  • APLM N/A
  • EPS Growth
  • SMX N/A
  • APLM N/A
  • EPS
  • SMX N/A
  • APLM N/A
  • Revenue
  • SMX N/A
  • APLM $198,000.00
  • Revenue This Year
  • SMX N/A
  • APLM $415.15
  • Revenue Next Year
  • SMX N/A
  • APLM N/A
  • P/E Ratio
  • SMX N/A
  • APLM N/A
  • Revenue Growth
  • SMX N/A
  • APLM N/A
  • 52 Week Low
  • SMX $1.06
  • APLM $4.47
  • 52 Week High
  • SMX $846.56
  • APLM $35.98
  • Technical
  • Relative Strength Index (RSI)
  • SMX 31.72
  • APLM 46.18
  • Support Level
  • SMX $1.48
  • APLM $5.95
  • Resistance Level
  • SMX $3.32
  • APLM $6.66
  • Average True Range (ATR)
  • SMX 0.40
  • APLM 0.66
  • MACD
  • SMX 0.07
  • APLM -0.04
  • Stochastic Oscillator
  • SMX 8.41
  • APLM 32.99

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

About APLM Apollomics Inc.

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

Share on Social Networks: